First Time Loading...
H

Hangzhou AGS MedTech Co Ltd
SSE:688581

Watchlist Manager
Hangzhou AGS MedTech Co Ltd
SSE:688581
Watchlist
Price: 83.87 CNY 2.18%
Updated: May 2, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
Hangzhou AGS MedTech Co Ltd

Wall Street analysts forecast Hangzhou AGS MedTech Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Hangzhou AGS MedTech Co Ltd is 149.94 CNY with a low forecast of 148.47 CNY and a high forecast of 154.35 CNY.

Lowest Forecast
Wall Street Target
148.47 CNY
77% Upside
Average Forecast
Wall Street Target
149.94 CNY
79% Upside
Highest Forecast
Wall Street Target
154.35 CNY
84% Upside
Lowest
Price Target
148.47 CNY
77% Upside
Average
Price Target
149.94 CNY
79% Upside
Highest
Price Target
154.35 CNY
84% Upside
Hangzhou AGS MedTech Co Ltd Competitors:
Price Targets
J
002223
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
17% Upside
SRTS
Sensus Healthcare Inc
88% Upside
MLAB
Mesa Laboratories Inc
20% Upside
HOLX
Hologic Inc
15% Upside
J
002223
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
17% Upside
SRTS
Sensus Healthcare Inc
88% Upside
MLAB
Mesa Laboratories Inc
20% Upside
HOLX
Hologic Inc
15% Upside
S
688410
SWS Hemodialysis Care Co Ltd
25% Upside
TCMD
Tactile Systems Technology Inc
47% Upside
COH
Cochlear Ltd
8% Downside
145720
Dentium Co Ltd
33% Upside

Revenue
Forecast

Revenue Estimate
Hangzhou AGS MedTech Co Ltd

For the last 1 year the compound annual growth rate for Hangzhou AGS MedTech Co Ltd's revenue is 21%. The projected CAGR for the next 3 years is 35%.

21%
Past Growth
35%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Hangzhou AGS MedTech Co Ltd

For the last 1 year the compound annual growth rate for Hangzhou AGS MedTech Co Ltd's operating income is 30%. The projected CAGR for the next 3 years is 31%.

30%
Past Growth
31%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Hangzhou AGS MedTech Co Ltd

For the last 1 year the compound annual growth rate for Hangzhou AGS MedTech Co Ltd's net income is 38%. The projected CAGR for the next 3 years is 22%.

38%
Past Growth
22%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Hangzhou AGS MedTech Co Ltd's stock price target?
Price Target
149.94 CNY

According to Wall Street analysts, the average 1-year price target for Hangzhou AGS MedTech Co Ltd is 149.94 CNY with a low forecast of 148.47 CNY and a high forecast of 154.35 CNY.

What is Hangzhou AGS MedTech Co Ltd's Revenue forecast?
Projected CAGR
35%

For the last 1 year the compound annual growth rate for Hangzhou AGS MedTech Co Ltd's revenue is 21%. The projected CAGR for the next 3 years is 35%.

What is Hangzhou AGS MedTech Co Ltd's Operating Income forecast?
Projected CAGR
31%

For the last 1 year the compound annual growth rate for Hangzhou AGS MedTech Co Ltd's operating income is 30%. The projected CAGR for the next 3 years is 31%.

What is Hangzhou AGS MedTech Co Ltd's Net Income forecast?
Projected CAGR
22%

For the last 1 year the compound annual growth rate for Hangzhou AGS MedTech Co Ltd's net income is 38%. The projected CAGR for the next 3 years is 22%.

ALPHA SPREAD
Join more than 133,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.